Subject: investment opportunity: pct-patent pending closed-loop stroke theranostic system

breakthrough medical devices and neurovascular innovations, I am reaching out to introduce a novel medical platform that addresses a critical bottleneck in Acute Ischemic Stroke treatment.We have developed a Closed-Loop Theranostic System for Targeted Artificial Cellular Respiration. The platform completely bypasses vascular obstructions caused by stroke, restoring cellular energy (ATP) production directly inside ischemic neurons within 45 seconds of activation. This is achieved through a synchronized system combining a bio-camouflaged, fullerene-shielded nanostructure and a non-invasive wearable optoelectronic helmet.Key milestones achieved to date include:Intellectual Property: Full international patent application filed under the PCT on September 06, 2026, covering all major global medical markets.Empirical Safety: ICP-MS assays confirmed 0.00% structural leakage of heavy metals over 72 hours, with a 98.7% cell viability rate in human neural tissue cultures.Proven Efficacy: Seahorse XF metrics recorded an immediate 82% recovery of baseline cellular ATP production during oxygen-glucose deprivation simulations, with zero localized thermal damage.The project is led by myself, Wafa Gariba (wrgarib@elmergib.edu.ly), as the sole inventor and applicant. We are currently opening a financing round to scale our GMP nanostructure manufacturing and refine the optoelectronic helmet into a clinical-grade prototype ready for Phase I human trials.I have attached our Non-Confidential Investment Proposal for your review. Would you be available for a brief, 15-minute introductory call next week to discuss our milestones and investment terms?Thank you for your time and consideration.Best regards,Wafa GaribaPrimary Applicant & InventorEl-Mergib Universitywrgarib@elmergib.edu.ly